U.S. plans to offer COVID-19 booster shots to citizens from September
Category: #healthcare  By Mateen Dalal  Date: 2021-08-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

U.S. plans to offer COVID-19 booster shots to citizens from September

The Biden administration intends to start administrating COVID-19 booster doses to Americans as early as mid- or late September, depending on approval from the US Food and Drug Administration (FDA). The announcement comes as the administration struggles to reclaim control of a pandemic it claimed to have contained just over a month ago.

Health officials concluded that most people should receive a booster shot eight months after their initial vaccination. They plan to announce the decision at the White House to inform Americans that individuals who have been inoculated with Moderna or Pfizer-BioNTech vaccines require additional protection against the Delta variant.

Nursing home residents, health care employees, and emergency responders would be the first recipients of the booster shots, followed by other senior citizens and the general public. Officials plan to administer the same vaccine they initially received.

Last week, Moderna Inc. and Pfizer Inc. along with its German partner BioNTech SE received approval from US regulators for the third dose of COVID-19 vaccination for immunocompromised patients.

Officials also believe that recipients of Johnson & Johnson's vaccine, which was approved as a one-dose regimen, may require an additional dose too. Only about 14 million Americans have received the Johnson & Johnson vaccine, which the government began offering in March.

The booster plan has been in discussions for several weeks, but a final decision on the roadmap was reached recently. The administration has more than 100 million doses on hand that can be used as boosters, plus tens of millions more in pharmacies and other locations.

The authority has also ordered extra supplies, which will arrive in the fall, and officials claim they are not concerned about running out. The only concern being the data from Israel which suggests the Pfizer-BioNTech vaccine's protection has decreased dramatically for elders who received their second dose in January or February.

Source Credit –

https://news.trust.org/item/20210817043006-qv3iv/

 

About Author

Mateen Dalal    

Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunicat...

Read More>>

More News By Mateen Dalal

Eastern China strengthens COVID-19 restrictions as new clusters arise
Eastern China strengthens COVID-19 restrictions as new clusters arise
By Mateen Dalal

Amid steady economic recovery under the country’s stringent zero-Covid-19 policy, cities in Ea...

Monkeypox virus found to be mutating faster than expected: Report
Monkeypox virus found to be mutating faster than expected: Report
By Mateen Dalal

Researchers studying the genetic nature of the monkeypox have recently claimed that the virus has be...

Bristol Myers Squibb to face USD 6.4 billion lawsuit over delayed drug
Bristol Myers Squibb to face USD 6.4 billion lawsuit over delayed drug
By Mateen Dalal

A U.S. judge has reportedly refused to toss out a USD 6.4 billion lawsuit that claimed pharma giant ...